• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,635.22 1,107.27
( 1.47%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Gujarat Terce Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524314
INE499G01013
12.4899567
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
10.23
25.49
EPS(TTM)
Face Value()
Div & Yield %
3.2
10
0
 

ur sugar industries ltd
Va Tech Wabag consolidated net profit rises 28.94% in the March 2026 quarter
May 22,2026
Net profit of Va Tech Wabag rose 28.94% to Rs 128.30 crore in the quarter ended March 2026 as against Rs 99.50 crore during the previous quarter ended March 2025. Sales rose 22.33% to Rs 1414.40 crore in the quarter ended March 2026 as against Rs 1156.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 25.47% to Rs 370.50 crore in the year ended March 2026 as against Rs 295.30 crore during the previous year ended March 2025. Sales rose 19.74% to Rs 3944.20 crore in the year ended March 2026 as against Rs 3294.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1414.401156.20 22 3944.203294.00 20
OPM %11.0412.18 -12.1012.82 -
PBDT171.40132.50 29 499.50390.30 28
PBT169.90131.10 30 493.30384.40 28
NP128.3099.50 29 370.50295.30 25